Korea's Hyundai Introduces Emergency Contraceptive ellaOne To Asia With No Additional Post-marketing Requirements
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Hyundai Pharm. Co. has launched HRA Pharma's oral emergency contraceptive ellaOne (ulipristal acetate) in South Korea, after Korea FDA granted the drug its first market approval in Asia
You may also be interested in...
Korea's Ildong Pharmaceutical Wins License To Sell Shionogi's IPF Drug In Korea
SEOUL - South Korea's Ildong Pharmaceutical Co., Ltd. said it plans to launch Shionogi & Co., Ltd.'s idiopathic pulmonary fibrosis product Pirespa (pirfenidone) in Korea in the first half of 2012 under an in-licensing deal signed July 11
Korea's Pharmacists, Doctors Clash Over Prescription Drug Sales; Ministry Calls For Expanded Painkiller Distribution
SEOUL - What started as a simple task of widening public access to some over-the-counter drugs has now evolved into a turf war between South Korea's pharmacist and doctor associations, and the Ministry of Health And Welfare is now calling for a new round of OTC distribution revisions before the first round has finished
U.S. Marketing Of Newly Approved Emergency Contraceptive Will Hinge On Longer Efficacy
FDA approval of Ella means prescription competition for OTC Plan B and generics. Will two days make a difference?